The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announces new appointments of cancer researchers to lead committees in its expansive scientific program. ECOG-ACRIN is at the forefront of ...
With funding, resources, and collaboration, experts can improve their analysis and help patients. How are ECOG-ACRIN and Caris Life Sciences teaming up to fight cancer? Their recent announcement will ...
Annual Meeting & Exposition provides insights into the prognostic utility of geriatric assessment tools and their role in ...
The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...
ECOG performance status: a measurement of how independently patients can perform everyday tasks. A score of 0 means they can ...
Fenske, MD led ECOG-ACRIN EA4151, the first randomized trial to compare treatment with or without stem cell transplant in patients with MRD-negative mantle cell lymphoma in first complete remission.
Hosted on MSN21d
High-dose chemotherapy followed by autologous stem cell transplant ineffective for patients with mantle cell lymphomaRituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission by the ECOG-ACRIN Cancer Research Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback